Cue Biopharma (CUE) Technical Analysis
As of 2026-09-11, CUE last traded at 28.74 USD (-5.77% on the day) and is in a range on the daily timeframe — insufficient history for 200-DMA. Nearest levels: 26.73 USD support below, 34.19 USD resistance above. 14-day RSI is 53.5 (neutral).
Last updated 2026-09-11 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ
Is CUE in an uptrend or downtrend?
Cue Biopharma is in a range — insufficient history for 200-DMA.
| Last close | 28.74 USD (-5.77%) |
|---|---|
| 20-day average | 27.974 USD |
| 50-day average | n/a |
| 200-day average | n/a |
Key support and resistance levels for CUE
Derived from swing pivots over the last 37 sessions:
| Level | Type | Strength | Touches |
|---|---|---|---|
| 34.19 USD | Resistance | Minor | 1 |
| 37 USD | Resistance | Minor | 1 |
| Level | Type | Strength | Touches |
|---|---|---|---|
| 26.73 USD | Support | Minor | 1 |
| 23.24 USD | Support | Minor | 1 |
CUE 52-week range, momentum and volatility
| 52-week high | 37 USD (22.3% below) |
|---|---|
| 52-week low | 23.24 USD (23.7% above) |
| 14-day RSI | 53.5 (Neutral) |
| 14-day ATR | 3.638 USD (12.66% of price, High volatility) |
Related research pages
Frequently asked questions
Is Cue Biopharma (CUE) in an uptrend or downtrend?
As of 2026-09-11, CUE is in a range on the daily timeframe — insufficient history for 200-DMA. Last close 28.74 USD vs 50-day average n/a and 200-day average n/a.
What are the key support and resistance levels for CUE?
Nearest support is around 26.73 USD (minor, 1 touch). Nearest resistance is around 34.19 USD (minor). Levels are derived from swing pivots over the last ~200 sessions.
What is CUE's 52-week high and low?
Over the last 52 weeks, CUE traded between 23.24 USD and 37 USD. It is currently 22.3% below its 52-week high.
Is CUE overbought or oversold?
The 14-day RSI is 53.5 — in a neutral 30–70 range. Momentum reads as neutral.
How volatile is CUE?
Its 14-day Average True Range is 3.638 (12.66% of price) — high volatility relative to price.